PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.7008
+0.0207 (3.04%)
At close: Feb 13, 2026, 4:00 PM EST
0.6929
-0.0079 (-1.13%)
After-hours: Feb 13, 2026, 7:35 PM EST
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $38.35 million as of February 13, 2026. Its market cap has decreased by -38.25% in one year.
Market Cap
38.35M
Enterprise Value
30.12M
1-Year Change
-38.25%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $38.35M, a decrease of -15.74%. That is a compound annual growth rate of -2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 38.35M | -8.96% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 41.20M |
| Lite Strategy | 41.18M |
| ABVC BioPharma | 40.99M |
| LeonaBio | 40.52M |
| Lisata Therapeutics | 40.31M |
| INmune Bio | 38.28M |
| Telomir Pharmaceuticals | 37.48M |
| Veru Inc. | 36.76M |